# Vaxcyte, Inc.: Form 8-K, filed Apr 20, 2023

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2023-04-20
- Accepted by EDGAR: Apr 19, 2023, 21:59 ET
- Period: 2023-04-18
- Accession: 0001193125-23-106984
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000119312523106984/d490519d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000119312523106984/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000119312523106984/d490519d8k.htm

Filed Apr 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-106984. Last ingested by Listed: Nov 2, 2026, 17:26 ET. No prices; not investment advice.